A retrospective study on Lymphopenia prevalence in subjects treated with dimethyl fumarate for multiple sclerosis at Providence MS center.
Phase of Trial: Phase III
Latest Information Update: 23 Feb 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 23 Feb 2016 New trial record